BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kim MN, Koh SJ, Kim JM, Im JP, Jung HC, Kim JS. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice. World J Gastroenterol 2014; 20(45): 17084-17091 [PMID: 25493020 DOI: 10.3748/wjg.v20.i45.17084]
URL: https://www.wjgnet.com/1007-9327/full/v20/i45/17084.htm
Number Citing Articles
1
Lifang Wang, Ju Cao, Congya Li, Liping Zhang. IL-27/IL-27 Receptor Signaling Provides Protection in Clostridium difficile-Induced ColitisThe Journal of Infectious Diseases 2018; 217(2): 198 doi: 10.1093/infdis/jix581
2
Emily S. Cribas, Joshua E. Denny, Jeffrey R. Maslanka, Michael C. Abt, Nancy E. Freitag. Loss of Interleukin-10 (IL-10) Signaling Promotes IL-22-Dependent Host Defenses against Acute Clostridioides difficile InfectionInfection and Immunity 2021; 89(5) doi: 10.1128/IAI.00730-20
3
Imran Khan, Guoxin Huang, Xiao-ang Li, Weilin Liao, Wai Kit Leong, Wenrui Xia, Xiqing Bian, Jianlin Wu, W.L. Wendy Hsiao. Mushroom polysaccharides and jiaogulan saponins exert cancer preventive effects by shaping the gut microbiota and microenvironment in Apc micePharmacological Research 2019; 148: 104448 doi: 10.1016/j.phrs.2019.104448
4
Katia Fettucciari, Pierfrancesco Marconi, Andrea Marchegiani, Alessandro Fruganti, Andrea Spaterna, Gabrio Bassotti. Invisible steps for a global endemy: molecular strategies adopted by Clostridioides difficileTherapeutic Advances in Gastroenterology 2021; 14: 175628482110327 doi: 10.1177/17562848211032797
5
Fenfen Zhou, Therwa Hamza, Ashley S Fleur, Yongrong Zhang, Hua Yu, Kevin Chen, Jonathon E Heath, Ye Chen, Haihui Huang, Hanping Feng. Mice with Inflammatory Bowel Disease are Susceptible toClostridium difficileInfection With Severe Disease OutcomesInflammatory Bowel Diseases 2018; 24(3): 573 doi: 10.1093/ibd/izx059
6
Fu-Chen Huang. The Interleukins Orchestrate Mucosal Immune Responses to Salmonella Infection in the IntestineCells 2021; 10(12): 3492 doi: 10.3390/cells10123492
7
Deiziane V.S. Costa, Natalie Pham, Andrea V. Loureiro, Suemin E. Yang, Brian W. Behm, Cirle A. Warren. Clostridioides difficile infection promotes gastrointestinal dysfunction in human and mice post-acute phase of the diseaseAnaerobe 2024; 87: 102837 doi: 10.1016/j.anaerobe.2024.102837
8
Séverine Péchiné, Anne Collignon. Immune responses induced by Clostridium difficileAnaerobe 2016; 41: 68 doi: 10.1016/j.anaerobe.2016.04.014
9
Xianrong Zhou, Huazhi Liu, Jing Zhang, Jianfei Mu, Zsolt Zalan, Ferenc Hegyi, Krisztina Takács, Xin Zhao, Muying Du. Protective effect of Lactobacillus fermentum CQPC04 on dextran sulfate sodium–induced colitis in mice is associated with modulation of the nuclear factor-κB signaling pathwayJournal of Dairy Science 2019; 102(11): 9570 doi: 10.3168/jds.2019-16840
10
Xi Jing, Anna A. Korchagina, Sergey A. Shein, Wayne T. Muraoka, Ekaterina Koroleva, Alexei V. Tumanov. IL-23 Contributes to Campylobacter jejuni-Induced Intestinal Pathology via Promoting IL-17 and IFNγ Responses by Innate Lymphoid CellsFrontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.579615
11
José L. Fachi, Marco A. R. Vinolo, Marco Colonna. Reviewing the Clostridioides difficile Mouse Model: Insights into Infection MechanismsMicroorganisms 2024; 12(2): 273 doi: 10.3390/microorganisms12020273
12
Hua Yu, Kevin Chen, Ying Sun, Mihaela Carter, Kevin W. Garey, Tor C. Savidge, Sridevi Devaraj, Mary Elizabeth Tessier, Erik C. von Rosenvinge, Ciaran P. Kelly, Marcela F. Pasetti, Hanping Feng, Helene F. Rosenberg. Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease SeverityClinical and Vaccine Immunology 2017; 24(8) doi: 10.1128/CVI.00037-17
13
Pingping Zhang, Ruitao Mao, Zhi Lv, Baoya Wang, Jianrong Su. Critical role of MAVS in the protection against Clostridium difficile-induced colitisMicrobial Pathogenesis 2018; 125: 306 doi: 10.1016/j.micpath.2018.09.035
14
Gabrio Bassotti, Alessandro Fruganti, Fabrizio Stracci, Pierfrancesco Marconi, Katia Fettucciari. Cytotoxic synergism of <i>Clostridioides difficile</i> toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseasesWorld Journal of Gastroenterology 2023; 29(4): 582-596 doi: 10.3748/wjg.v29.i4.582